BCL2 and cancer: These results are similar with other topoisomerase 1 inhibitors such as camptothecin and irinotecan, which are also capable of modulating Bcl-2 family member expression and activating caspase-9 and -3, provoking mitochondrial apoptotic cell death in human cancer cells [65–67].